Baeta® Long (Byetta® Long)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceExenatideExenatide
Similar drugsTo uncover
  • Baeta®
    solution PC 
    AstraZeneca UK Ltd     United Kingdom
  • Baeta® Long
    powder PC 
    AstraZeneca UK Ltd     United Kingdom
    • Dosage form: & nbspPowder for the preparation of a suspension for subcutaneous administration of prolonged action
    ATX: & nbsp

    A.10.B.X.04   Exenatide

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004205
    Date of registration:21.03.2017
    Expiration Date:21.03.2022
    The owner of the registration certificate:AstraZeneca UK LtdAstraZeneca UK Ltd United Kingdom
    Manufacturer: & nbsp
    Illustrated instructions
      Instructions
      Up